European Archives - Page 207 of 1001 - European Medical Journal

Liver Elastography for Methotrexate-Induced Fibrosis

Methotrexate (MTX), an antimetabolite, has a multifarious mechanism of action that most notably includes folate antagonism, effects on…

Surgery and Quality of Life in Cervical Cancer

Cervical cancer is established as a major cause of morbidity and mortality among females globally.1 In Kenya, and other countries with…

Renal Replacement Therapy

End-stage liver disease (ESLD) represents a non-reversible, advanced stage of cirrhosis, where the hepatic architecture is distorted and…

What is PEAL Syndrome?

Endoscopic retrograde cholangiopancreatography (ERCP) includes specialised techniques, such as sphincterotomy, balloon dilation…

Is Muscle Loss Linked to Heart Failure Risk?

Researchers at Johns Hopkins University, Baltimore, Maryland, USA, have investigated muscle loss as a risk factor of heart failure, emphasising the underexplored association between thigh muscle measurements and heart failure.

Interview: Anil Dhawan

Anil Dhawan – Professor of Paediatric Hepatology, King’s College London, UK. I started in paediatric hepatology in 1992, when I got a…

Precision Medicine in Lung Cancer Treatment

Nathan Merrill, University of Michigan, Ann Arbor, USA, presents his work on a precision medicine-based platform, which is used to…

Optimising Outcomes in Patients with Hepatitis-Associated Aplastic Anaemia

Exploring strategies to optimise outcomes for those with HAAA, and assessing both safety and efficacy of HSCT was the goal of an emerging piece of research.

EAHAD 2024 – Interview with the Congress President

EMJ sat down with EAHAD President, Wolfgang Miesbach, live at this year’s congress in Frankfurt, Germany. Miesbach highlighted key…

Dietary Acid Load Significantly Associated with Cirrhosis-Related Mortality

According to research, dietary acid load is significantly associated with cirrhosis-related mortality, and there is further need of investigating underlying mechanisms, as well as establishing optimal DAL levels in patients with cirrhosis.